Related Experiment Videos

Morphine-induced changes in striatal dopamine mechanisms not evoked from the dopamine nerve terminals

N E Andén, M Grabowska-Andén

The Journal of Pharmacy and Pharmacology

|November 1, 1978

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

The Journal of pharmacology and experimental therapeutics·1991

Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice.

European journal of pharmacology·1991

A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.

Journal of medicinal chemistry·1991

Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.

European journal of pharmacology·1991

Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.

European journal of pharmacology·1991

B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.

Journal of neural transmission. General section·1990

See all related articles